Primovist 0.25 mmol/ml

Primovist 0.25 mmol/ml is a medicine authorised by Swissmedic under authorisation number 56936. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 December 2004 and the authorisation is valid without a time limit. ATC code V08CA10 places the medicine in the group Contrast media.

Dispensing category B
Authorisation number 56936
ATC V08CA10
Synthetic medicines

Authorisation data
Authorisation number	56936
Name	Primovist 0.25 mmol/ml
Full name	Primovist 0.25 mmol/ml, Injektionslösung
Authorisation holder	Bayer (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	V08CA10
First authorisation	10 December 2004
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Primovist 0.25 mmol/ml, Injektionslösung	B	10 December 2004

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
2	1	Spritze(n)	V08CA10	14.02.0.	B
21	1	Spritze(n)	V08CA10	14.02.0.	B

Scroll the table sideways

Other medicines from this authorisation holder

Adempas 0.5 mgAuthorisation number 62903 · ATC C02KX05B Adempas junior 0.15 mg/mlAuthorisation number 69929 · ATC C02KX05B AleveAuthorisation number 53810 · ATC M01AE02D Alka-SeltzerAuthorisation number 8671 · ATC N02BA01D Ambelvist 0.1 mmol/ mlAuthorisation number 70405 · ATC V08CA13B Ambelvist 0.1 mmol/ mlAuthorisation number 70441 · ATC V08CA13B Ambelvist 0.1 mmol/ nlAuthorisation number 70440 · ATC V08CA13B AngeliqAuthorisation number 56275 · ATC G03FA17B

Frequently asked questions

Is Primovist 0.25 mmol/ml authorised in Switzerland?

Yes. Primovist 0.25 mmol/ml is authorised by Swissmedic under authorisation number 56936, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Primovist 0.25 mmol/ml have?

Primovist 0.25 mmol/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Primovist 0.25 mmol/ml?

The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.